These results suggest that TSP1 may regulate CD47 levels to improve macrophage-mediated cancer cell killing beyond the well-described SIRPα-CD47 interaction, providing a new mechanism to explain the role of CD47 in innate anti-tumor responses. Here, CD47 is linked to neoplasm.